FutureFuel Releases Third Quarter 2025 Results Reports Net Loss of $9.3 Million or $0.21 per Diluted Share, and Adjusted EBITDA of ($6.8) Million GlobeNewswire November 10, 2025 BATESVILLE, Ark., Nov. 10, 2025 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the […]
The RealReal Announces Third Quarter 2025 Results GlobeNewswire November 10, 2025 Company delivers profitable growth with record high quarterly Revenue and Gross Merchandise Value, strengthening its leadership position in luxury resale SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) — The RealReal, Inc. (Nasdaq: REAL)–the world's largest online marketplace for authenticated, resale luxury goods–today reported financial
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum GlobeNewswire November 10, 2025 ROCKAWAY, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services
Hallador Energy Company Reports Third Quarter 2025 Financial and Operating Results GlobeNewswire November 10, 2025 – Q3 Total Revenue up 40% YoY to $146.8 Million –– Q3 Net Income Increases to $23.9 Million or $0.56 Earnings per Share –– Q3 Operating Cash Flow of $23.2 Million –– Q3 Adjusted EBITDA up 1.6x to $24.9 Million
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 10, 2025 – Submission of New Drug Application (NDA) for lorundrostat planned for late-2025/Q1 2026 – – Completed enrollment in Explore-OSA trial; topline results anticipated in Q1 2026 – – Conference call today at 4:30 p.m. ET – RADNOR, Pa., Nov.
Mobile Infrastructure Reports Third Quarter 2025 Financial Results GlobeNewswire November 10, 2025 –Contract Volumes Continued to Increase, Up 8.0% Year-to-Date– –Asset Rotation Strategy On Track; Expect To Have Approximately $30 Million of Non-Core Assets Under Contract Or Sold By The End of 2025– –Recently Completed $100 Million Asset-Backed Securitization Increases Capital Flexibility and Facilitates Portfolio
Gemini Reports Third Quarter 2025 Results GlobeNewswire November 10, 2025 NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (Gemini) (NASDAQ: GEMI) today reported its third quarter 2025 financial results in a shareholder letter which can be found on its Investor Relations website at https://investors.gemini.com. Management will host a conference call at
Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones GlobeNewswire November 10, 2025 Late-Stage Neuroinflammation Platform Advancing Global Registrational Programs in Guillain-Barre Syndrome (GBS) and Geographic Atrophy (GA) Current Tanruprubart GBS Dossier On Track for MAA Filing in January 2026; Potential to Be the First Approved Targeted and Fast-Acting Therapy for
HF Foods Reports Solid Third Quarter 2025 Financial Results GlobeNewswire November 10, 2025 Net Revenue increased 2.9% to $307.0 millionGAAP Net Loss decreased 77.2% to $0.9 millionAdj. EBITDA up 42% to $11.7 million LAS VEGAS, Nov. 10, 2025 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading distributor
Outset Medical Reports Third-Quarter Results GlobeNewswire November 10, 2025 SAN JOSE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2025 and revised its 2025